Budget impact of including ribociclib in combination with letrozole on US payer formulary: first-line treatment of post-menopausal women with HR+/HER2− advanced or metastatic breast cancer

2018 ◽  
Vol 34 (12) ◽  
pp. 2143-2150 ◽  
Author(s):  
Rohit Mistry ◽  
Gaurav Suri ◽  
Kate Young ◽  
Robert Hettle ◽  
Jessica R. May ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Budget Impact ◽  
Metastatic Breast ◽  
Line Treatment ◽  
First Line ◽  
Menopausal Women ◽  
Post Menopausal ◽  
First Line Treatment

Exemestane and Chemotherapy as First-line Treatment of Metastatic Breast Cancer: Results of a Phase II Study

2010 ◽  
Vol 10 (4) ◽  
pp. 313-317 ◽  
Author(s):  
Juan de la Haba-Rodriguez ◽  
Rosario González Mancha ◽  
Gumersindo Pérez Manga ◽  
Enrique Aranda Aguilar ◽  
José Manuel Baena Cañada ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Metastatic Breast ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment

Epirubicin-Vinorelbine Intravenous Combination Followed by Oral Vinorelbine as First-Line Treatment in Metastatic Breast Cancer

2007 ◽  
Vol 93 (6) ◽  
pp. 544-549 ◽  
Author(s):  
Antonio Ardizzoia ◽  
Ilaria Colombo ◽  
Monica Giordano ◽  
Stefania Aglione ◽  
Luciano Isa ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Metastatic Breast ◽  
Line Treatment ◽  
First Line ◽  
Oral Vinorelbine ◽  
First Line Treatment
Sign in / Sign up

Export Citation Format

Share Document